Phospho-STAT5A (Ser726) Recombinant antibody, PBS Only

Non-treated and GM-CSF treated TF-1 cells were subjected to SDS PAGE followed by western blot with 80138-2-RR (Phospho-STAT5A (Ser726) antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours. The membrane was stripped and re-blotted with Beta Actin (66009-1-Ig) antibody as a loading control. This data was developed using the same antibody clone with 80138-2-PBS in a different storage buffer formulation.

Immunofluorescent analysis of (4% PFA) fixed GM-CSF treated TF-1 cells using Phospho-STAT5A (Ser726) antibody (80138-2-RR, Clone: 240709D6 ) at dilution of 1:400 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2). This data was developed using the same antibody clone with 80138-2-PBS in a different storage buffer formulation.

1x10^6 untreated TF-1 cells (dash lines) and 100 nM Calyculin A (30 minutes) treated TF-1 cells (full lines) were intracellularly stained with 0.4 μg Phospho-STAT5A (Ser726) Recombinant antibody (80138-2-RR, Clone: 240709D6, red) and Multi-rAb CoraLite ® Plus 647-Goat Anti-Rabbit Recombinant Secondary Antibody (H+L) (Cat.NO. RGAR005). Rabbit IgG Isotype Control Recombinant Antibody (98136-1-RR, Clone: 240953C9, blue) was parallel stained as control. Cells were fixed with 4% PFA. This data was developed using the same antibody clone with 80138-2-PBS in a different storage buffer formulation.